Delcath Systems, Inc. (DCTH)
9.78
+0.25
(+2.62%)
USD |
NASDAQ |
Feb 20, 16:00
9.79
+0.01
(+0.10%)
After-Hours: 20:00
Delcath Systems Research and Development Expense (Quarterly) : 7.986M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | -- |
| Danaher Corp. | 438.00M |
| CytoSorbents Corp. | 0.918M |
| Cardiac Biotech Solutions, Inc. | 0.028M |
| Odyssey Health, Inc. | 0.00 |